Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Efstathiou

Showing results (181-190 of 278) with videos related to

Pageof 28
Sort By:
Clinical Genitourinary Cancer|May 3, 2017
Disparities in the Receipt of Local Treatment of Node-positive Prostate CancerVinayak Muralidhar, Brandon A Mahal, Brent S Rose, et al.
Urology|April 15, 2014
Weight gain on androgen deprivation therapy: which patients are at highest risk?Daniel M Seible, Xiangmei Gu, Andrew S Hyatt, et al.
BJU International|August 4, 2015
Association between very small tumour size and increased cancer-specific mortality after radical prostatectomy in lymph node-positive prostate cancerVinayak Muralidhar, Brandon A Mahal, Michelle D Nezolosky, et al.
European Urology|January 2, 2017
Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing TherapyRoss E Krasnow, Michael Drumm, Hannah J Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancerAyal A Aizer, Jonathan J Paly, Anthony L Zietman, et al.
World Journal of Urology|January 27, 2019
SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancerJeffrey J Leow, Jens Bedke, Karim Chamie, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2013
Models of care and NCCN guideline adherence in very-low-risk prostate cancerAyal A Aizer, Jonathan J Paly, Anthony L Zietman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2018
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II TrialJohn J Coen, Peixin Zhang, Philip J Saylor, et al.
European Urology|January 14, 2017
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital ExperienceNicholas J Giacalone, William U Shipley, Rebecca H Clayman, et al.
Pageof 28

Showing results (181-190 of 278) with videos related to

Sort By:
Pageof 28
Clinical Genitourinary Cancer|May 3, 2017
Disparities in the Receipt of Local Treatment of Node-positive Prostate CancerVinayak Muralidhar, Brandon A Mahal, Brent S Rose, et al.
Urology|April 15, 2014
Weight gain on androgen deprivation therapy: which patients are at highest risk?Daniel M Seible, Xiangmei Gu, Andrew S Hyatt, et al.
BJU International|August 4, 2015
Association between very small tumour size and increased cancer-specific mortality after radical prostatectomy in lymph node-positive prostate cancerVinayak Muralidhar, Brandon A Mahal, Michelle D Nezolosky, et al.
European Urology|January 2, 2017
Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing TherapyRoss E Krasnow, Michael Drumm, Hannah J Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancerAyal A Aizer, Jonathan J Paly, Anthony L Zietman, et al.
World Journal of Urology|January 27, 2019
SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancerJeffrey J Leow, Jens Bedke, Karim Chamie, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2013
Models of care and NCCN guideline adherence in very-low-risk prostate cancerAyal A Aizer, Jonathan J Paly, Anthony L Zietman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2018
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II TrialJohn J Coen, Peixin Zhang, Philip J Saylor, et al.
European Urology|January 14, 2017
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital ExperienceNicholas J Giacalone, William U Shipley, Rebecca H Clayman, et al.
Pageof 28